$16.9 B

ABMD Mkt cap, 03-Aug-2018

$180 M

ABIOMED Revenue Q1, 2019
ABIOMED Gross profit (Q1, 2019)149.2 M
ABIOMED Gross profit margin (Q1, 2019), %82.9%
ABIOMED Net income (Q1, 2019)90.1 M
ABIOMED EBIT (Q1, 2019)46.7 M
ABIOMED Cash, 30-Jun-201861.3 M

ABIOMED Income Statement

Annual

USDFY, 2014FY, 2015Y, 2016FY, 2017FY, 2018

Revenue

183.6 m230.3 m329.5 m445.3 m593.7 m

Revenue growth, %

25%43%35%

Cost of goods sold

98.6 m

Gross profit

495.2 m

Gross profit Margin, %

83%

R&D expense

66.4 m75.3 m

General and administrative expense

218.2 m262.7 m

Operating expense total

284.5 m436.6 m

EBIT

8.4 m28.7 m65.1 m90.1 m157.1 m

EBIT margin, %

5%12%20%20%26%

Pre tax profit

8.5 m28.8 m65.8 m91.3 m160.4 m

Income tax expense

1.2 m(84.9 m)27.7 m39.2 m48.3 m

Net Income

7.4 m113.7 m38.1 m52.1 m112.2 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019

Revenue

44.3 m46.2 m48.8 m51.9 m62 m73.4 m76.4 m85.8 m103 m103 m114.7 m132.5 m132.8 m180 m

Cost of goods sold

30.9 m

Gross profit

149.2 m

Gross profit Margin, %

83%

R&D expense

7.7 m7.8 m9.1 m8.7 m8.4 m10.2 m11.6 m13.8 m15.7 m18.1 m16.3 m16.9 m19.4 m21.3 m

General and administrative expense

26.2 m24.4 m31.6 m29.5 m30.1 m37.3 m39.8 m41.9 m51 m53.1 m53.9 m60.6 m60.1 m81.1 m

Operating expense total

42.9 m41.6 m50.3 m47.8 m48.3 m58.4 m63.5 m68.4 m81.8 m88.4 m89.3 m99.4 m101.1 m133.3 m

EBIT

1.4 m4.6 m(1.5 m)4.2 m13.7 m15 m12.8 m17.4 m21.2 m14.5 m25.4 m33.1 m31.7 m46.7 m

EBIT margin, %

3%10%(3%)8%22%20%17%20%21%14%22%25%24%26%

Pre tax profit

1.4 m4.7 m4.2 m13.7 m15.1 m13 m17.5 m21.4 m14.7 m25.8 m33.8 m32.5 m48.5 m

Income tax expense

370 k258 k226 k336 k1 m6.3 m5.2 m6.9 m8.5 m5.9 m10.4 m(3.6 m)8 m(41.6 m)

Net Income

1.1 m4.4 m(1.7 m)3.8 m12.7 m8.9 m7.7 m10.6 m12.9 m8.9 m15.4 m37.4 m24.5 m90.1 m

ABIOMED Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

20.9 m22.4 m48.2 m39 m43 m

Accounts Receivable

24.4 m31.8 m42.8 m54.1 m70 m

Inventories

13.9 m16.8 m26.7 m34.9 m50.2 m

Current Assets

118 m220.1 m288.4 m327 m494.3 m

PP&E

6.9 m9.1 m23.2 m87.8 m117.2 m

Goodwill

38 m31.5 m33 m31 m35.8 m

Total Assets

205.4 m338.4 m423.9 m550.4 m786.4 m

Accounts Payable

7.7 m10.4 m9.4 m20.6 m23.6 m

Short-term debt

Current Liabilities

30.4 m39.3 m46.5 m69.6 m84.7 m

Long-term debt

Total Liabilities

98.3 m96.9 m

Additional Paid-in Capital

436.1 m465 m508.6 m566 m619.9 m

Retained Earnings

(250.9 m)(137.2 m)(99.1 m)(47 m)140.5 m

Total Equity

168.4 m291.6 m368.8 m452.1 m689.5 m

Financial Leverage

1.2 x1.2 x1.1 x1.2 x1.1 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019

Cash

10.1 m22.6 m34.7 m17.5 m19.5 m40.4 m54.4 m53.2 m38.3 m54.7 m61.1 m44 m44.5 m61.3 m

Accounts Receivable

21.1 m23 m22.8 m23.1 m28.4 m34.4 m37.1 m36.8 m41.3 m46.6 m50.2 m53.6 m57.3 m67.5 m

Inventories

15.6 m14.8 m13.9 m13.4 m15.4 m21.2 m23 m25.5 m29.1 m31.5 m32.1 m36.9 m40.6 m55.8 m

Current Assets

110.6 m119.7 m127.2 m135.3 m160.6 m244.1 m265.4 m281.7 m300.3 m319.9 m333.4 m350.9 m370.2 m497.3 m

PP&E

6.4 m7 m6.7 m7.4 m7.6 m10.2 m11.4 m15 m26 m50.2 m60.9 m92.8 m97.7 m127.3 m

Goodwill

37.3 m38 m37.7 m36.9 m35.3 m32.2 m32.7 m31.7 m32.3 m32.6 m30.6 m33.2 m34.3 m33.9 m

Total Assets

181 m193.4 m206.2 m215.5 m240.8 m352 m373.4 m391.6 m429.3 m474.9 m501 m652.2 m694.7 m812 m

Accounts Payable

6.2 m6.1 m6.8 m7.6 m8.2 m8.6 m8.8 m8.8 m8.4 m14.1 m14.6 m12.8 m16.7 m25.7 m

Current Liabilities

24 m26.4 m29 m27.1 m31.4 m36.3 m34.5 m37.7 m43.2 m51.9 m58.9 m59 m63.4 m76.7 m

Total Liabilities

30.3 m32.9 m35.8 m40 m45.1 m44 m42.3 m46.1 m52 m76.5 m83.6 m85.2 m89.8 m88.7 m

Additional Paid-in Capital

427.2 m431.8 m441.3 m447.4 m457.9 m474.5 m489.5 m496 m520.8 m536.9 m546.8 m580 m592.1 m638 m

Retained Earnings

(258.9 m)(254.5 m)(252.6 m)(248.8 m)(236.1 m)(128.4 m)(120.6 m)(110.1 m)(86.2 m)(77.3 m)(61.9 m)65.7 m90.2 m230.5 m

Total Equity

150.7 m160.5 m170.4 m175.5 m195.7 m308.1 m331.1 m345.5 m377.3 m398.4 m417.4 m567 m604.9 m723.4 m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x1.2 x1.1 x1.1 x1.1 x1.1 x1.2 x1.2 x1.2 x1.1 x1.1 x

ABIOMED Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

7.4 m113.7 m38.1 m52.1 m112.2 m

Depreciation and Amortization

2.8 m3.3 m6.2 m11 m

Accounts Receivable

(1.3 m)(8 m)(11 m)(11.6 m)(15.3 m)

Inventories

(622 k)(7 m)(11 m)(12.3 m)(15.7 m)

Accounts Payable

(54 k)3.4 m(2.6 m)7.6 m4.4 m

Cash From Operating Activities

23.5 m43.3 m76.8 m115.1 m192.5 m

Purchases of PP&E

(2.8 m)(5.2 m)(15.6 m)(50.4 m)(55.9 m)

Cash From Investing Activities

(22.3 m)(49.9 m)(57.7 m)(126.3 m)(180.8 m)

Cash From Financing Activities

9.6 m9.5 m7.2 m3.9 m(9.1 m)

Income Taxes Paid

1.3 m1.2 m848 k1.4 m4.6 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2019

Net Income

(664 k)3.7 m(1.7 m)3.8 m12.7 m8.9 m7.7 m10.6 m12.9 m8.9 m15.4 m90.1 m

Depreciation and Amortization

1.3 m1.9 m3 m

Accounts Receivable

1.9 m123 k22.8 m23.1 m28.4 m34.4 m37.1 m36.8 m41.3 m46.6 m50.2 m1.9 m

Inventories

(876 k)(69 k)13.9 m13.4 m15.4 m21.2 m23 m25.5 m29.1 m31.5 m32.1 m(7.8 m)

Accounts Payable

(1.5 m)(1.7 m)6.8 m7.6 m8.2 m8.6 m8.8 m8.8 m8.4 m14.1 m14.6 m2.7 m

Cash From Operating Activities

5.1 m13.6 m46.6 m

Purchases of PP&E

(1.2 m)(2.3 m)(15.1 m)

Cash From Investing Activities

(10.1 m)(9.1 m)34.8 m

Cash From Financing Activities

5.2 m8.1 m(61.8 m)

Income Taxes Paid

1.1 m3 m

ABIOMED Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information